NVNO enVVeno Medical Corporation

NASDAQ
$8.67

enVVeno Medical Corporation (NVNO) is expected to report earnings on October 29, 2026, before the market open. The stock has had a Post-Earnings Announcement Drift (PEAD) of -19.0% since its last earnings release on July 30, 2026.

enVVeno Medical Reported Earnings
Thursday, July 30, 2026 · 12:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Oct 29
Thursday · Before Open
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $10.37

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About enVVeno Medical Corporation

enVVeno Medical Corporation is a medical device company. It focuses in the treatment of venous disease. enVVeno Medical Corporation, formerly known as Hancock Jaffe Laboratories Inc., is based in IRVINE, CA.

Sector

Healthcare

Industry

Medical Instruments/Supply

Charts powered in part by Lightweight Charts™ by TradingView.